Table 1 Clinicopathological features of 150 patients with follicular thyroid tumors
From: Mutation profiles of follicular thyroid tumors by targeted sequencing
| Â | FTC, n (%) | FTA, n (%) | FT-UMP, n (%) | WDT-UMP, n(%) |
|---|---|---|---|---|
Cases | 53 | 48 | 32 | 17 |
Sex | ||||
 Male | 16 (30) | 16 (33) | 12 (37) | 5 (29) |
 Female | 37 (70) | 32 (67) | 20 (63) | 12 (71) |
Age at diagnosis | ||||
 Mean year | 46 | 45 | 46 | 44 |
 Median (Quartiles) | 50 (31–61) | 47 (34–54) | 44 (37–58) | 43 (33–55) |
Tumor size, cm | ||||
 Mean size | 3.1 | 2.5 | 3.4 | 1.9 |
 Median (Quartiles) | 2.5 (1.5–4.0) | 2.5 (1.8–3.0) | 2.5 (1.4–5.4) | 1.2 (1.0–2.7) |
Variant type | ||||
 Hürthle cell tumor | 14 (26) | 12 (25) | 6 (19) | 2 (18) |
 Non-Hürthle cell tumor | 39 (74) | 36 (75) | 26 (81) | 14 (82) |
Histologic type a | ||||
 Minimally invasive | 25 (47) |  |  |  |
 Encapsulated angioinvasive | 15 (28) |  |  |  |
 Widely invasive | 13 (25) |  |  |  |
Lymph node metastasis | ||||
 Present | 5 (9) | – | – | – |
Distant metastasis | ||||
 Present | 2 (4) | – | – | – |
AJCC stage | ||||
 I~II | 51 (96) | – | – | – |
 III~IV | 2 (4) | – | – | – |
Follow-up time | ||||
 Median (Quartiles) | 56 (46–65) | 55 (42–65) | 55 (47–60) | 55 (29–74) |
Disease Persistence/Recurrence | ||||
 Yes | 8 (15) | 0 (0) | 0 (0) | 0 (0) |
 No | 45 (85) | 48 (100) | 32 (100) | 16 (100) |